---
title: "Aashka Hospitals Ltd (543346) — Share Price, Financials & Analysis"
symbol: "543346"
company: "Aashka Hospitals Ltd"
canonical: "https://tapetide.com/stocks/543346"
isin: "INE0EAX01014"
nse_symbol: "AASHKALTD"
bse_code: "543346"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 198.88
generated_at: "2026-09-13T21:39:19.657Z"
---

# Aashka Hospitals Ltd (543346)

Canonical page: https://tapetide.com/stocks/543346

## Company

- **NSE Symbol:** AASHKALTD
- **BSE Code:** 543346
- **ISIN:** INE0EAX01014
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2021-09-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aashkahospitals.in

## About

Incorporated in 2012, Aashka Hospitals Ltd operates Multi Disciplinary Private Hospital, Clinics, and Pharmacies[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:34:59.663154Z.

- **Market Cap:** ₹198.88 Cr
- **Classification:** SME
- **P/E (reported):** 59.4
- **EPS (reported):** ₹1.01
- **Book Value:** ₹44.13
- **Price to Book:** 1.93
- **Dividend Yield:** 0%
- **ROE:** 3.28%
- **ROCE:** 5.26%
- **Debt to Equity:** 0.08
- **Revenue (yearly):** ₹23.01 Cr
- **Net Income:** ₹3.34 Cr
- **EBITDA:** ₹5.24 Cr
- **52-Week High:** ₹99.5
- **52-Week Low:** ₹59
- **RSI (14):** 61.22

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -10.8% over past five years.
- Company has a low return on equity of 2.56% over last 3 years.
- Earnings include an other income of Rs.2.86 Cr.
- Debtor days have increased from 87.8 to 111 days.
- Working capital days have increased from -5.31 days to 104 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 27.99% | 809.9% | -36.62% |
| ebitda margin growth | -30.85% | -36.75% | -3.8% |
| net income growth | 1.21% | 46% | -7% |
| revenue growth | -11.5% | 7% | -11% |
| roce | -3.84% | — | 6.11% |
| roe | 33.88% | 1% | -76.69% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 24.82 | 28.42 | 11.32 | 11.54 | 7.41 | 10.8 | 12.07 | 12.36 | 10.28 | 10.44 | 12.57 |
| Expenses | 19.41 | 19.41 | 12.06 | 10.8 | 7.91 | 9.97 | 8.44 | 7.89 | 10.49 | 8.33 | 9.44 |
| Operating Profit | 5.41 | 9.01 | -0.74 | 0.74 | -0.5 | 0.83 | 3.63 | 4.47 | -0.21 | 2.11 | 3.13 |
| OPM % | 21.8 | 31.7 | -6.54 | 6.41 | -6.75 | 7.69 | 30.07 | 36.17 | -2.04 | 20.21 | 24.9 |
| Other Income | 0.04 | 0.04 | 0.09 | 0.06 | 3.06 | 2.61 | 1.61 | 0.07 | 4.2 | 0.9 | 1.96 |
| Interest | 1.43 | 1.43 | 1.23 | -0.17 | 3.17 | 1.46 | 1.45 | 1.02 | 0.7 | 0.63 | 0.55 |
| Depreciation | 1.45 | 1.45 | 1.44 | 1.44 | 1.49 | 1.47 | 1.45 | 1.58 | 1.37 | 1.46 | 1.51 |
| Profit before tax | 2.57 | 6.17 | -3.32 | -0.47 | -2.1 | 0.51 | 2.34 | 1.94 | 1.92 | 0.92 | 3.03 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 17.65 | 17.09 | 16.49 | 14.58 | 15.22 | 15.51 |
| Net Profit | 2.57 | 6.17 | -3.33 | -0.47 | -2.1 | 0.42 | 1.93 | 1.62 | 1.65 | 0.78 | 2.56 |
| EPS in Rs | 1.43 | 2.64 | -1.42 | -0.2 | -0.9 | 0.18 | 0.82 | 0.69 | 0.71 | 0.33 | 1.09 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 27.67 | 27.23 | 40.69 | 39.73 | 18.94 | 22.87 | 22.65 | 23.01 |
| Expenses | 18.08 | 18.41 | 30.72 | 31.16 | 18.59 | 18.41 | 18.37 | 17.77 |
| Operating Profit | 9.59 | 8.82 | 9.97 | 8.57 | 0.35 | 4.46 | 4.28 | 5.24 |
| OPM % | 34.66 | 32.39 | 24.5 | 21.57 | 1.85 | 19.5 | 18.9 | 22.77 |
| Other Income | 0.06 | 0.02 | 0 | 0.13 | 3.1 | 4.21 | 4.26 | 2.86 |
| Interest | 5.75 | 4.9 | 3.25 | 2.96 | 3.09 | 2.91 | 1.72 | 1.18 |
| Depreciation | 2.54 | 2.56 | 2.61 | 2.9 | 2.93 | 2.92 | 2.95 | 2.97 |
| Profit before tax | 1.36 | 1.38 | 4.11 | 2.84 | -2.57 | 2.84 | 3.87 | 3.95 |
| Tax % | 0 | 0 | 0 | 16.55 | 0 | 17.25 | 15.5 | 15.7 |
| Net Profit | 1.36 | 1.38 | 4.11 | 2.37 | -2.57 | 2.36 | 3.27 | 3.34 |
| EPS in Rs | 0.76 | 0.77 | 2.28 | 1.01 | -1.1 | 1.01 | 1.4 | 1.43 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 17.16 | 17.91 | 18 | 23.37 | 23.37 | 23.37 | 23.37 | 23.4 |
| Reserves | -1.8 | 6.28 | 11.25 | 73.2 | 70.55 | 72.91 | 76.17 | 79.87 |
| Borrowings | 32.99 | 30.92 | 27.87 | 28.21 | 29.19 | 20.39 | 12.61 | 8.24 |
| Other Liabilities | 5.71 | 4.93 | 7.96 | 4.34 | 4.92 | 4.78 | 3.91 | 4.33 |
| Total Liabilities | 54.06 | 60.04 | 65.08 | 129.12 | 128.03 | 121.45 | 116.06 | 115.84 |
| Fixed Assets | 46.36 | 44.12 | 49.49 | 48.46 | 45.47 | 42.78 | 40.79 | 41.52 |
| CWIP | 0.08 | 0 | 0 | 0 | 0.05 | 0.45 | 0.88 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7.62 | 15.92 | 15.59 | 80.66 | 82.51 | 78.22 | 74.39 | 74.32 |
| Total Assets | 54.06 | 60.04 | 65.08 | 129.12 | 128.03 | 121.45 | 116.06 | 115.84 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -0.96 | 14.5 | -62.63 | 1.01 | 7.18 | 9.19 | 7.79 |
| Cash from Investing Activity | — | -0.24 | -7.98 | -1.87 | -0.07 | -0.63 | -1.38 | -2.82 |
| Cash from Financing Activity | — | 4.16 | -7.97 | 62.64 | 1.05 | -7.62 | -7.2 | -3.24 |
| Net Cash Flow | — | 2.96 | -1.44 | -1.86 | 1.99 | -1.08 | 0.61 | 1.73 |
| Free Cash Flow | — | -1.2 | 6.52 | -64.5 | 0.94 | 6.55 | 7.81 | 4.97 |
| CFO/OP | — | -8 | 148 | -725 | 289 | 172 | 229 | 160 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 45.64 | 90.48 | 65.66 | 71.84 | 132.2 | 76.93 | 76.06 | 110.56 |
| Inventory Days | 51.35 | 66.55 | 30.28 | 34.97 | 56.59 | 48.75 | 58.63 | 49.26 |
| Days Payable | 296.91 | 247.49 | 241.09 | 101.11 | 365 | 263.54 | 130.46 | 194.5 |
| Cash Conversion Cycle | -199.92 | -90.46 | -145.15 | 5.71 | -176.21 | -137.86 | 4.23 | -34.68 |
| Working Capital Days | -93.26 | 19.57 | -38.48 | -34.27 | -126.42 | -123.21 | 3.38 | 103.9 |
| ROCE % | — | 12.14 | 13.12 | 6.38 | 0.42 | 4.8 | 4.07 | 4.05 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 91.67% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.33% | 61.33% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 27.2% | 31.83% | 31.8% | 30.72% | 29.98% | 30.02% | 29.94% | 30.16% | 29.98% | 30.3% |
| Others | 8.33% | 11.52% | 6.89% | 6.91% | 8% | 8.73% | 8.7% | 8.78% | 8.56% | 8.69% | 8.37% |
| No. of Shareholders | 57 | 2771 | 3245 | 3171 | 2435 | 2066 | 1641 | 1244 | 1174 | 1172 | 1126 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 3 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 81.42 | Buy |
| EMA (10) | 81.35 | Buy |
| SMA (20) | 77.2 | Buy |
| EMA (20) | 79.07 | Buy |
| SMA (50) | 75.54 | Buy |
| EMA (50) | 77.14 | Buy |
| SMA (100) | 77.65 | Buy |
| EMA (100) | 78.71 | Buy |
| SMA (200) | 85.63 | Sell |
| EMA (200) | 83.99 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 61.2 | Neutral |
| MACD (12,26,9) | 2.43 | Buy |
| Stochastic (14,3,3) | 92.02 | Sell |
| ADX (14) | 26.74 | Buy |
| Williams %R (14) | -9.62 | Sell |
| ATR (14) | 5.39 | High Volatility |
| ROC (12) | 18.03 | Buy |
| Stoch RSI (14) | 75.25 | Neutral |
| UO (7,14,28) | 71.81 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-27 | [Board Meeting Outcome for Board Meeting Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5dd5dad-622a-4a5d-8577-e205d0c3f9e2.pdf) |
| 2026-08-27 | [Shareholder Meeting - 14Th AGM On 24 September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb2a88d3-0f1b-4d45-b11d-f33b24a7baad.pdf) |
| 2026-08-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=555ab1d7-ea31-40fd-ba5c-719eef730c55.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2650aebb-4a60-488a-a229-62ca57407c8a.pdf) |
| 2026-07-28 | [Announcement under Regulation 30 (LODR)-Updates on Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a6007d-7e29-41e3-8074-796e1fdac7a7.pdf) |
| 2026-07-28 | [Board Meeting Outcome for Board Meeting Outcome - Incorporation Of Subsidiary Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=255e7dcf-caf1-4128-a276-946c173487c3.pdf) |
| 2026-07-15 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1971b1e0-6381-432c-ba61-4408e1201e17.pdf) |
| 2026-05-29 | [Board Meeting Outcome for Board Meeting Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1366de2-0cec-4d89-abe2-e7cb4e3bccaf.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86539101-0f7f-491b-83a1-15128c5ad8af.pdf) |
| 2026-05-23 | [Board Meeting Intimation for Audited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33e2e114-d3ef-4e16-b031-e69553e86608.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-29 | [Result - March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=804f9ac8-b816-4bf8-800c-22dca5e7a45e.pdf) |
| 2025-11-10 | [Results - Financial Result For Half Year Ended 30 September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8779578-cd2c-4e63-a8f0-a1ced81e6d26.pdf) |
| 2025-05-27 | [Results - Financial Results For March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c60511f-c909-41e6-a7da-046b0dbf0789.pdf) |
| 2024-10-30 | [Results - Financial Results For Half Year Ended On September 30 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc6acbf3-09f1-459f-ba0b-808f42a4ef13.pdf) |
| 2024-05-30 | [Results - Financial Year Ended On March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=012edba7-f881-41ff-9ee9-addc013f3427.pdf) |
| 2023-11-09 | [Results - Financial Results For The Half Year Ended On September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7371ad1f-fb34-44ff-8d05-72df60272b37.pdf) |
| 2023-06-09 | [Results-Financial Year Ending March 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=461c31d5-d221-42d8-b7d9-a79d4d14fa90.pdf) |
| 2023-04-14 | [Results - For The Half Year Ended On September 30, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0d84709-199b-4e09-ac61-241002326a9d.pdf) |
| 2023-02-21 | [Revised Result For The Financial Year Ending On March 31, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8dc8792-f449-43c0-b8ab-311bec6c7afb.pdf) |
| 2023-01-18 | [Board Meeting Outcome for Board Meeting Outcome - Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6bd1f14-a1cc-469b-be32-688a02dd9471.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 5 Nov 2025 - Board meeting on 10 Nov 2025 to approve H1 unaudited results for period ended 30 Sep 2025. | [Board Meeting Intimation for Unaudited Financial Results 5 Nov 2025 - Board meeting on 10 Nov 2025 to approve H1 unaudited results for period ended 30 Sep 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5adc1827-34cb-4626-9842-54c71a795ac8.pdf) |
| 30 Jan - Board approved reclassification of Gagan Bharari LLP from Promoter to Public on Jan 29, 2026; pending exchange approval. | [Outcome Of Board Meeting Considering Re-Classification From Promoter / Promoter Group Category To Public Category 30 Jan - Board approved reclassification of Gagan Bharari LLP from Promoter to Public on Jan 29, 2026; pending exchange approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8e42caeb-9a7d-4da9-b066-043b211f2a41.pdf) |
| 30 Jan - Allotment of 153 equity shares under ESOP Scheme 2021 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 30 Jan - Allotment of 153 equity shares under ESOP Scheme 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a943a2c-365a-4a2c-a4a2-ddd311f15e1d.pdf) |
| 3 Feb - Applied to reclassify Gagan Bharari Enterprises LLP from promoter to public; holds nil shares. | [Intimation Of Application For Reclassification Of Promoter Under Regulation 31A Of The SEBI LODR Regulations 3 Feb - Applied to reclassify Gagan Bharari Enterprises LLP from promoter to public; holds nil shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fbd608a0-7af1-4a57-bddc-dc6daa0f93e4.pdf) |
| 29 Jan - Quick Heal appointed Savita Nehra, Amartya Mukherjee, Nitin Bhogan; promoted Netra Deshpande effective January 29, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 29 Jan - Quick Heal appointed Savita Nehra, Amartya Mukherjee, Nitin Bhogan; promoted Netra Deshpande effective January 29, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7a1767d-bbd2-458f-80f8-bd797a980e76.pdf) |
| 29 Apr - 29 April 2026: Aashka Hospitals confirms it is not a SEBI large corporate. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - 29 April 2026: Aashka Hospitals confirms it is not a SEBI large corporate.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9a417b98-528e-4ca8-94d0-30deff14e5ff.pdf) |
| 29 Apr - 29 April 2026: Aashka Hospitals confirms it is not a SEBI large corporate. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - 29 April 2026: Aashka Hospitals confirms it is not a SEBI large corporate.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9a417b98-528e-4ca8-94d0-30deff14e5ff.pdf) |
| 27 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for period ending Mar 31, 2026. | [Closure of Trading Window 27 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited results for period ending Mar 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7072a7da-1346-4ea6-9b64-5cd0b7e5f4b7.pdf) |
| 27 Feb - Allotment of 18015 Equity Shares under ESOP Scheme 2021 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 27 Feb - Allotment of 18015 Equity Shares under ESOP Scheme 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e72d897c-eb1f-42a3-a118-2b824fee55a0.pdf) |
| 15 Apr - Certificate for the Quarter ended March 2026 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Certificate for the Quarter ended March 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3bb0458-fb54-4a6b-9fa1-c96038bac255.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bab713b7-d7eb-4ec9-9d9b-8ca1be9a16d8.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ad73d51-53a7-4dd7-ac89-070b00084c84.pdf) |
| Jul 2023 | [Concall - Jul 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/16fe8fe3-af1f-40c0-afe6-81ec8f80efb1.pdf) |
| Jul 2022 | [Concall - Jul 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2456a55c-a9f6-442e-b555-ec58f962d1d1.pdf) |
| Feb 2023 | [Concall - Feb 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7044b0db-93b6-41af-835e-cafe491b4813.pdf) |
| Apr 2023 | [Concall - Apr 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1eb9f7d3-5771-4539-9075-207edb2387b2.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04deca59-8d1b-4c62-86c9-03de6699daa1.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8048e69d-d9a2-4852-9fc3-fc02569e85b8.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/039842d3-b601-417f-81d3-0364e0799b20.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ed80c58-b545-4a81-ae79-088cb8445977.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b3f8344-043a-40b4-bf03-5770f71d8e73.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c0a4cb48-b656-4352-a74c-60fb1d94a155.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/13fc2390-27c4-4daa-89f9-625a3c4caaeb.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539678/74035539678.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539678/68886539678.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/539678/5396780320.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T21:39:19.657Z.